- UN proposal demands combatants protect hospitals and doctors Updated: Apr-29-16 7:23 pm
UNITED NATIONS - A proposed U.N. resolution that supporters hope will be adopted next week demands that all parties to conflicts protect medical workers, hospitals and medical facilities against violence and attacks - and face justice if they don't.
- The Latest: Maine boosts availability of overdose antidote Updated: Apr-29-16 6:30 pm
AUGUSTA, Maine - The Latest on veto votes by the Maine Legislature (all times local):
- Reservation hospitals face Friday deadline to not lose funds Updated: Apr-29-16 5:46 pm
SIOUX FALLS, South Dakota - The government agency that administers hospitals on the Pine Ridge and Rosebud Indian reservations faces a Friday deadline to reach crucial agreements with federal health officials to avoid losing funding.
- Federal investigators fault VA review of Texas wait times Updated: Apr-29-16 4:36 pm
AUSTIN, Texas - Federal authorities have determined that an investigation by the U.S. Department of Veterans Affairs into the manipulation of wait times for Texas veterans seeking care was "deficient and unreasonable."
- Valeant files overdue financial report, ending debt default Updated: Apr-29-16 4:36 pm
Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S. financial report for 2015 on Friday. The badly tarnished Canadian drugmaker also announced a slate of mostly new nominees for elections to its board in June.
- Correction: Illinois Budget-Home Care-Overtime story Updated: Apr-29-16 1:21 pm
SPRINGFIELD, Illinois - In a story April 28 about overtime pay for personal home care providers, The Associated Press reported erroneously that providers who are unable to find replacements to work the extra hours would have to do the work for free. They will be approved for overtime pay if no backup providers can be found.
- Correction: Abbott-St Jude Acquisition story Updated: Apr-29-16 11:12 am
In a story April 28 about an Abbott Laboratories plan to buy St. Jude Medical, The Associated Press reported erroneously the deal's value. Abbott Laboratories will spend $25 billion to buy St. Jude Medical, not $19.3 billion.
- Regulators negotiate agreement with psychiatric hospital Updated: Apr-29-16 10:40 am
OLYMPIA, Washington - Federal regulators have agreed to negotiate an agreement with the Washington state agency that oversees the troubled Western State Hospital to avoid the loss of federal funds.
- 9 workers laid off at Regional Health hospital in Rapid City Updated: Apr-29-16 10:18 am
RAPID CITY, South Dakota - Rapid City-based Regional Health has laid off nine workers in an ongoing staff shake-up instigated last year by a new top executive.
- Medivation rejects Sanofi bid, Sanofi to go to shareholders Updated: Apr-29-16 9:49 am
NEW YORK - Drug maker Sanofi says it is still committed to its $9.3 billion acquisition offer for Medivation, even though the pharmaceutical firm has rejected its bid.
- AstraZeneca says it will cut costs Updated: Apr-29-16 3:33 am
LONDON - Anglo-Swedish drugmaker AstraZeneca says first-quarter earnings fell 12 percent as it announced plans to cut costs so it can devote more resources to cancer drugs.
- Sanofi profits stable, strong sales in emerging markets Updated: Apr-29-16 2:13 am
PARIS - Sanofi says drugs sales in emerging markets helped keep its profits stable in the first quarter despite losses caused by Venezuela's collapsing currency.
- UK company fined for misleading Australians over painkillers Updated: Apr-29-16 12:12 am
SYDNEY - An Australian court ordered a British consumer goods company on Friday to pay 1.7 million Australian dollars ($1.3 million) in penalties after ruling that the company misled consumers about the effectiveness of a popular painkiller.
- Amgen posts 1Q sales, profit jumps, raises profit forecasts Updated: Apr-28-16 8:16 pm
Amgen beat and then raised profit expectations after surging sales of its medicines, tight cost controls and other factors lifted the biologic drugmaker's first-quarter profit by 17 percent.
- Iowa regent directs furniture company that won no-bid deal Updated: Apr-28-16 6:58 pm
IOWA CITY, Iowa - A prominent regent failed to publicly disclose that she was a paid director for a national furniture company before its local distributor signed a lucrative no-bid contract with the University of Iowa last year, records show.
- Drug company to pay back rebates owed to Washington Updated: Apr-28-16 6:43 pm
SEATTLE - The state attorney general's office has announced a national pharmaceutical company accused of underpaying drug rebates owed to Medicaid will pay Washington $22.9 million.
- Gilead 1Q profit tumbles on slower hepatitis C drug sales Updated: Apr-28-16 6:04 pm
WASHINGTON - Gilead Science Inc.'s earnings tumbled more than 17 percent in the first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut into sales.
- South Dakota tribe sues feds over ER closure Updated: Apr-28-16 5:46 pm
SIOUX FALLS, South Dakota - A Native American tribe in South Dakota sued the federal government Thursday over the nearly five-month closure of the only emergency room on its reservation.
- Amgen beats Street 1Q forecasts Updated: Apr-28-16 4:21 pm
THOUSAND OAKS, California _ Amgen Inc. (AMGN) on Thursday reported first-quarter profit of $1.9 billion.
- Manchester VA improves number of claims paid, officials say Updated: Apr-28-16 3:29 pm
MANCHESTER, New Hampshire - Officials with the Manchester VA Medical Center say they have more than doubled the amount of claims paid out following complaints over delayed payments to local health care providers through the Veterans Choice Program.
- Aetna tops Street 1Q forecasts, hikes 2016 forecast Updated: Apr-28-16 2:14 pm
Aetna's first-quarter earnings slid nearly 7 percent as enrollment dipped, but the nation's third-largest health insurer topped Wall Street expectations and hiked its 2016 profit forecast.
- Shareholders criticize Pfizer after scrapped Allergan deal Updated: Apr-28-16 1:28 pm
Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to Ireland, company executives faced sharp criticism from shareholders at their annual meeting.
- Sanofi makes $9.3 billion bid for American firm Medivation Updated: Apr-28-16 11:49 am
PARIS - Drug maker Sanofi made a $9.3 billion bid for San Francisco pharmaceutical firm Medivation on Thursday, part of the firm's effort to expand its portfolio of cancer treatments.
- IU hospital in Muncie taking precautions for Legionella Updated: Apr-28-16 11:19 am
MUNCIE, Indiana - An Indiana University hospital in Muncie is keeping water restrictions in place after tests last week found a positive test for the Legionella bacteria.
- AbbVie tops Street 1Q forecasts, buying StemCentrx Updated: Apr-28-16 9:49 am
NEW YORK - AbbVie Inc. on Thursday reported a boost in first-quarter profit on higher sales of the drug Humira and said it will buy cancer drug developer StemCentrx for more than $5.8 billion.